Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IOngoingD-0862-2017

Drug recall · May 31, 2017

Infant 25% DEXTROSE Injection recall

Why: Presence of Particulate Matter: human hair found within an internal sample syringe.

Class I: a reasonable chance the product could cause serious harm or death.

The recall

Product

Infant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit of Use Single-dose Syringe per carton, Rx only, Hospira Inc., Lake Forest, IL 60045, NDC 0409-1775-10

Lots / codes

Lot 58382EV*, Exp 1OCT 2017, *lot may be followed by 01 or 02

Quantity
71,550 syringes
Company
Hospira Inc., Lake Forest, IL
Distribution
Nationwide in the USA and Puerto Rico
Initiated
April 21, 2017 · Voluntary: Firm initiated
Classified
May 24, 2017
Reported
May 31, 2017
How notified
Press Release

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Glucose

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.